Understanding the characteristics of idiopathic osteoporosis by a systematic review and meta-analysis.

Bone mineral density; Bone turnover markers; Parathyroid hormone; Sex steroid; Sex hormone-binding globulin

Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
12 2023
Historique:
received: 30 05 2023
accepted: 20 08 2023
medline: 2 11 2023
pubmed: 21 9 2023
entrez: 21 9 2023
Statut: ppublish

Résumé

To understand the pathophysiology of idiopathic osteoporosis (IOP) better, we conducted a systematic review and meta-analysis of bone mineral density (BMD), hormones, and bone turnover markers (BTMs) between IOP patients and healthy controls. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, an appropriate search query was created, and three databases, including PubMed, ScienceDirect, and Google Scholar, were searched for screening relevant original articles. Feasible information, both qualitative and quantitative, was extracted and used to conduct meta-analyses. Publication bias and heterogeneity among studies were evaluated using appropriate statistical tools. A total of 21 studies were included in the meta-analysis. There was reduced BMD at the lumbar spine (LS) (pooled: SDM: -2.38, p-value: 0.0001), femoral neck (FN) (pooled: SDM: -1.75 p-value: 0.0001), total hip (TH) (pooled: SDM: -1.825, p-value: 0.0001) and distal radius (DR) (pooled: SDM of -0.476, p-value: 0.0001), of which LS was the most affected site. There was no significant change in BTMs compared with healthy controls. Total estradiol (SDM: -1.357, p-value: 0.003) was reduced, and parathyroid hormone (PTH) (SDM: 1.51, p-value: 0.03) and sex hormone-binding globulin (SHBG) (SDM: 1.454, p-value: 0.0001) were elevated in IOP patients compared with healthy controls. Our meta-analysis, the first of its kind on IOP, defines it as showing BMD decline maximally at LS compared with healthy controls without any alterations in the BTMs. Further studies are required to understand gender differences and the significance of altered hormonal profiles in this condition.

Identifiants

pubmed: 37733181
doi: 10.1007/s12020-023-03505-5
pii: 10.1007/s12020-023-03505-5
doi:

Substances chimiques

Parathyroid Hormone 0
Estradiol 4TI98Z838E

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

513-526

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

J.A. Kanis, Lancet 359, 1929 (2002)
pubmed: 12057569 doi: 10.1016/S0140-6736(02)08761-5
F. Albright, E.C. Reifentein, The Parathyriod Glands and Metabolic Bone Disease. pp. 393 (1948).
J.A. Kanis, E.V. McCloskey, H. Johansson, C. Cooper, R. Rizzoli, J.-Y. Reginster, Reginster, Osteoporos. Int 24, 23 (2013)
pubmed: 23079689 doi: 10.1007/s00198-012-2074-y
G. Duque, B.R. Troen, J. Am. Geriatr. Soc. 56, 935 (2008)
pubmed: 18454751 doi: 10.1111/j.1532-5415.2008.01764.x
A. Ostertag, M. Cohen-Solal, M. Audran, E. Legrand, C. Marty, D. Chappard, M.-C. de Vernejoul, Bone 44, 413 (2009)
pubmed: 19071239 doi: 10.1016/j.bone.2008.11.004
J.E. Aaron, R.M. Francis, M. Peacock, and N.B. Makins, Clin. Orthop. Relat. Res. 294 (1989)
B.Y. Reed, J.E. Zerwekh, K. Sakhaee, N.A. Breslau, F. Gottschalk, C.Y. Pak, J. Bone Min. Res 10, 1218 (1995)
doi: 10.1002/jbmr.5650100812
E.S. Kurland, C.J. Rosen, F. Cosman, D. McMahon, F. Chan, E. Shane, R. Lindsay, D. Dempster, J.P. Bilezikian, J. Clin. Endocrinol. Metab. 82, 2799 (1997)
pubmed: 9284699
Y. Pernow, E.M. Hauge, K. Linder, E. Dahl, M. Sääf, Calcif. Tissue Int 84, 430 (2009)
pubmed: 19308628 doi: 10.1007/s00223-009-9239-5
T.G. Goetz, N. Nair, S. Shiau, R.R. Recker, J.M. Lappe, D.W. Dempster, H. Zhou, B. Zhao, X. Guo, W. Shen, T.L. Nickolas, M. Kamanda-Kosseh, M. Bucovsky, J. Stubby, E. Shane, A. Cohen, Osteoporos. Int 33, 659 (2022)
pubmed: 34665288 doi: 10.1007/s00198-021-06196-8
P. Gillberg, A.G. Johansson, S. Ljunghall, Calcif. Tissue Int 64, 209 (1999)
pubmed: 10024377 doi: 10.1007/s002239900604
P. Gillberg, A.G. Johansson, W.F. Blum, T. Groth, S. Ljunghall, Calcif. Tissue Int 68, 67 (2001)
pubmed: 11310349 doi: 10.1007/BF02678143
Y. Pernow, M. Thorén, M. Sääf, R. Fernholm, B. Anderstam, E.M. Hauge, K. Hall, Bone 47, 959 (2010)
pubmed: 20813216 doi: 10.1016/j.bone.2010.08.017
L. Feng, Y. Wang, J. Zhou, B. Tian, B. Xia, Mol. Med Rep. 18, 67 (2018)
pubmed: 29750314 pmcid: 6059696
S.L. Ferrari, S. Deutsch, C. Baudoin, M. Cohen-Solal, A. Ostertag, S.E. Antonarakis, R. Rizzoli, M.C. de Vernejoul, Bone 37, 770 (2005)
pubmed: 16168727 doi: 10.1016/j.bone.2005.06.017
J.M. Patsch, T. Kohler, A. Berzlanovich, C. Muschitz, C. Bieglmayr, P. Roschger, H. Resch, P. Pietschmann, J. Bone Min. Res 26, 1584 (2011)
doi: 10.1002/jbmr.344
Y. Pernow, B. Granberg, M. Sääf, L. Weidenhielm, Calcif. Tissue Int 78, 90 (2006)
pubmed: 16467976 doi: 10.1007/s00223-005-0158-9
L.V. Hedges and I. Olkin, in Statistical Methods for Meta-Analysis, edited by L. V. Hedges and I. Olkin (Academic Press, San Diego, 1985), pp. 107–145
T.B. Huedo-Medina, J. Sánchez-Meca, F. Marín-Martínez, J. Botella, Psychol Methods 11, 193 (2006)
pubmed: 16784338 doi: 10.1037/1082-989X.11.2.193
J.P.T. Higgins, S.G. Thompson, J.J. Deeks, D.G. Altman, BMJ 327, 557 (2003)
pubmed: 12958120 pmcid: 192859 doi: 10.1136/bmj.327.7414.557
A. Al Kaissi, C. Windpassinger, F.B. Chehida, M.B. Ghachem, N.M. Nassib, V. Kenis, E. Melchenko, E. Morenko, S. Ryabykh, J.G. Hofstaetter, F. Grill, R. Ganger, S.G. Kircher, Medicine 96, e7863 (2017)
pubmed: 28858097 pmcid: 5585491 doi: 10.1097/MD.0000000000007863
H.M. Heshmati, S. Khosla, Ann. Med Interne 149, 77 (1998)
W.D. Leslie, L.M. Lix, Osteoporos. Int 25, 1 (2014)
pubmed: 23797847 doi: 10.1007/s00198-013-2409-3
M.Z. Allende-Vigo, P R Health Sci. J. 26, 91 (2007)
pubmed: 17722420
S. Vasikaran, R. Eastell, O. Bruyère, A.J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H.A. Morris, S. Silverman, T. Trenti, D.A. Wahl, C. Cooper, J.A. Kanis; for the IOF-IFCC Bone Marker Standards Working Group. Osteoporos. Int 22, 391 (2011)
pubmed: 21184054 doi: 10.1007/s00198-010-1501-1
M.J. Seibel, M. Lang, W.J. Geilenkeuser, Clin. Chem. 47, 1443 (2001)
pubmed: 11468235 doi: 10.1093/clinchem/47.8.1443
S. Vasikaran, R. Eastell, O. Bruyère, A.J. Foldes, P. Garnero, A. Griesmacher, M. McClung, H.A. Morris, S. Silverman, T. Trenti, D.A. Wahl, C. Cooper, J.A. Kanis; IOF-IFCC Bone Marker Standards Working Group. Osteoporos. Int 22, 391 (2011)
pubmed: 21184054 doi: 10.1007/s00198-010-1501-1
R.B. Greenblatt, M. Oettinger, C.S. Bohler, J. Am. Geriatr. Soc. 24, 173 (1976)
pubmed: 1254880 doi: 10.1111/j.1532-5415.1976.tb04294.x
C. Lormeau, B. Soudan, M. d’Herbomez, P. Pigny, B. Duquesnoy, B. Cortet, Bone 34, 933 (2004)
pubmed: 15193539 doi: 10.1016/j.bone.2004.01.024
E. Legrand, C. Hedde, Y. Gallois, I. Degasne, F. Boux de Casson, E. Mathieu, M.F. Baslé, D. Chappard, M. Audran, Bone 29, 90 (2001)
pubmed: 11472897 doi: 10.1016/S8756-3282(01)00478-1
S.P. Tuck, A.C. Scane, W.D. Fraser, M.J. Diver, R. Eastell, R.M. Francis, Bone 43, 999 (2008)
pubmed: 18817902 doi: 10.1016/j.bone.2008.08.123
A. El Maghraoui, Z. Ouzzif, A. Mounach, A. Ben-Ghabrit, L. Achemlal, A. Bezza, I. Ghozlani, Bone 49, 853 (2011)
pubmed: 21723429 doi: 10.1016/j.bone.2011.06.022
M. Dixit, S.B. Poudel, S. Yakar, Mol. Cell Endocrinol. 519, 111052 (2021)
pubmed: 33068640 doi: 10.1016/j.mce.2020.111052
A. Cohen, J. Hostyk, E.H. Baugh, C.M. Buchovecky, V.S. Aggarwal, R.R. Recker, J.M. Lappe, D.W. Dempster, H. Zhou, M. Kamanda-Kosseh, M. Bucovsky, J. Stubby, D.B. Goldstein, E. Shane, Bone 154, 116253 (2022)
pubmed: 34743040 doi: 10.1016/j.bone.2021.116253
M.E. Cohen-Solal, C. Baudoin, M. Omouri, D. Kuntz, M.C. De Vernejoul, J. Bone Min. Res 13, 1909 (1998)
doi: 10.1359/jbmr.1998.13.12.1909
S.F. Evans, M.W. Davie, Ann. Rheum. Dis. 59, 269 (2000)
pubmed: 10733473 pmcid: 1753105 doi: 10.1136/ard.59.4.269
P. Pietschmann, S. Kudlacek, J. Grisar, S. Spitzauer, W. Woloszczuk, R. Willvonseder, M. Peterlik, Eur. J. Clin. Invest 31, 444 (2001)
pubmed: 11380597 doi: 10.1046/j.1365-2362.2001.00836.x
I. Van Pottelbergh, S. Goemaere, H. Zmierczak, D. De Bacquer, J.M. Kaufman, J. Bone Min. Res 18, 303 (2003)
doi: 10.1359/jbmr.2003.18.2.303
I. Van Pottelbergh, S. Goemaere, H. Zmierczak, J.M. Kaufman, J. Clin. Endocrinol. Metab. 89, 4949 (2004)
pubmed: 15472190 doi: 10.1210/jc.2003-032081
M.R. Rubin, D.H. Schussheim, C.A.M. Kulak, E.S. Kurland, C.J. Rosen, J.P. Bilezikian, E. Shane, Osteoporos. Int 16, 526 (2005)
pubmed: 15300364 doi: 10.1007/s00198-004-1716-0
J.H. Macdonald, S.F. Evans, M.W.J. Davie, C.A. Sharp, Osteoporos. Int 18, 1371 (2007)
pubmed: 17103082 doi: 10.1007/s00198-006-0223-x
Z.H. Al-oanzi, S.P. Tuck, S.S. Mastana, G.D. Summers, D.B. Cook, R.M. Francis, H.K. Datta, Osteoporos. Int 19, 951 (2008)
pubmed: 18038108 doi: 10.1007/s00198-007-0516-8
P. Peris, V. Ruiz-Esquide, A. Monegal, L. Alvarez, M.J. Martínez de Osaba, A. Martínez-Ferrer, R. Reyes, N. Guañabens, Clin. Exp. Rheumatol. 26, 986 (2008)
pubmed: 19210860
B. Lapauw, Y. Taes, S. Goemaere, K. Toye, H.-G. Zmierczak, J.-M. Kaufman, J. Clin. Endocrinol. Metab. 94, 4300 (2009)
pubmed: 19773402 doi: 10.1210/jc.2009-0568
A. Cohen, X.S. Liu, E.M. Stein, D.J. McMahon, H.F. Rogers, J. Lemaster, R.R. Recker, J.M. Lappe, X.E. Guo, E. Shane, J. Clin. Endocrinol. Metab. 94, 4351 (2009)
pubmed: 19837923 pmcid: 2775661 doi: 10.1210/jc.2009-0996
S. Ruiz-Gaspà, J. Blanch-Rubió, M. Ciria-Recasens, J. Monfort, L. Tío, N. Garcia-Giralt, X. Nogués, J.C. Monllau, J. Carbonell-Abelló, L. Pérez-Edo, Calcif. Tissue Int 86, 220 (2010)
pubmed: 20101397 doi: 10.1007/s00223-010-9336-5
A. Cohen, R.R. Recker, J. Lappe, D.W. Dempster, S. Cremers, D.J. McMahon, E.M. Stein, J. Fleischer, C.J. Rosen, H. Rogers, R.B. Staron, J. Lemaster, E. Shane, Osteoporos Int 23, 171 (2012)
pubmed: 21365462 doi: 10.1007/s00198-011-1560-y
J. Paccou, J. Dewailly, B. Cortet, Jt. Bone Spine 79, 78 (2012)
doi: 10.1016/j.jbspin.2011.06.002
B.M. Misof, S. Gamsjaeger, A. Cohen, B. Hofstetter, P. Roschger, E. Stein, T.L. Nickolas, H.F. Rogers, D. Dempster, H. Zhou, R. Recker, J. Lappe, D. McMahon, E.P. Paschalis, P. Fratzl, E. Shane, K. Klaushofer, J. Bone Min. Res 27, 2551 (2012)
doi: 10.1002/jbmr.1699
M. Laroche, Rheumatol. Int 32, 2101 (2012)
pubmed: 21499877 doi: 10.1007/s00296-011-1930-y
A. Ostertag, C. Collet, C. Chappard, S. Fernandez, E. Vicaut, M. Cohen-Solal, M.-C. de Vernejoul, Bone 52, 48 (2013)
pubmed: 23010106 doi: 10.1016/j.bone.2012.09.020

Auteurs

Sreyanko Sadhukhan (S)

Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

Shruti Sethi (S)

Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

Singh Rajender (S)

Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

Ambrish Mithal (A)

Endocrinology & Diabetes, Max Super Speciality Hospital, Delhi, India. ambrishmithal@hotmail.com.

Naibedya Chattopadhyay (N)

Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow, India.
Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH